Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Chinese (SSE) Healthcare Sector Analysis

UpdatedNov 24, 2025
DataAggregated Company Financials
Companies472
  • 7D-0.5%
  • 3M-5.6%
  • 1Y9.2%
  • YTD17.2%

In the last week, the Healthcare industry is flat overall, with Beijing Wantai Biological Pharmacy Enterprise standing out by going down 8.0%. As for the the longer term, the industry is up 9.2% over the past 12 months. Earnings are forecast to grow by 25% annually.

Sector Valuation and Performance

Has the Chinese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 28 Nov 2025CN¥6.4tCN¥2.3tCN¥145.1b38.5x44.1x2.8x
Sun, 26 Oct 2025CN¥6.6tCN¥2.3tCN¥146.2b40.1x45.5x2.9x
Tue, 23 Sep 2025CN¥6.8tCN¥2.2tCN¥142.4b39.9x48.1x3.1x
Thu, 21 Aug 2025CN¥6.9tCN¥2.2tCN¥152.4b41.5x45.3x3.1x
Sat, 19 Jul 2025CN¥6.4tCN¥2.2tCN¥150.0b37.6x42.9x2.9x
Mon, 16 Jun 2025CN¥6.1tCN¥2.2tCN¥150.0b35.5x40.6x2.8x
Wed, 14 May 2025CN¥5.7tCN¥2.2tCN¥149.8b34.2x37.8x2.6x
Fri, 11 Apr 2025CN¥5.5tCN¥2.2tCN¥158.8b30.8x34.7x2.5x
Sun, 09 Mar 2025CN¥5.7tCN¥2.2tCN¥153.9b32.6x37x2.5x
Tue, 04 Feb 2025CN¥5.4tCN¥2.2tCN¥153.8b30.9x34.9x2.4x
Thu, 02 Jan 2025CN¥5.6tCN¥2.2tCN¥153.7b31.6x36.2x2.5x
Sat, 30 Nov 2024CN¥5.9tCN¥2.2tCN¥154.1b34.1x38.4x2.6x
Mon, 28 Oct 2024CN¥5.9tCN¥2.2tCN¥158.4b32.3x37.3x2.6x
Wed, 25 Sep 2024CN¥4.8tCN¥2.2tCN¥161.8b27.1x29.9x2.2x
Fri, 23 Aug 2024CN¥4.9tCN¥2.3tCN¥167.0b26.6x29.4x2.2x
Sun, 21 Jul 2024CN¥5.2tCN¥2.3tCN¥166.9b28.5x31.2x2.3x
Tue, 18 Jun 2024CN¥5.5tCN¥2.3tCN¥164.9b29.4x33.2x2.4x
Thu, 16 May 2024CN¥6.0tCN¥2.3tCN¥167.5b32x35.8x2.6x
Sat, 13 Apr 2024CN¥5.6tCN¥2.3tCN¥173.1b29.9x32.4x2.5x
Mon, 11 Mar 2024CN¥5.8tCN¥2.3tCN¥178.9b29.6x32.3x2.5x
Wed, 07 Feb 2024CN¥5.4tCN¥2.3tCN¥179.8b25.8x30.2x2.4x
Fri, 05 Jan 2024CN¥6.4tCN¥2.3tCN¥176.9b34.7x36.4x2.8x
Sun, 03 Dec 2023CN¥6.8tCN¥2.3tCN¥177.2b37.5x38.1x3x
Tue, 31 Oct 2023CN¥6.6tCN¥2.3tCN¥184.4b34.4x35.5x2.8x
Thu, 28 Sep 2023CN¥6.5tCN¥2.3tCN¥185.3b33x35x2.8x
Sat, 26 Aug 2023CN¥6.0tCN¥2.3tCN¥193.3b30x31.1x2.6x
Mon, 24 Jul 2023CN¥6.5tCN¥2.3tCN¥193.0b33.4x33.6x2.9x
Wed, 21 Jun 2023CN¥6.7tCN¥2.3tCN¥191.8b34.8x34.7x2.9x
Fri, 19 May 2023CN¥6.9tCN¥2.3tCN¥192.3b35x36x3.1x
Sun, 16 Apr 2023CN¥7.3tCN¥2.2tCN¥235.2b38.2x31.2x3.3x
Tue, 14 Mar 2023CN¥7.1tCN¥2.2tCN¥229.9b38.4x30.9x3.2x
Thu, 09 Feb 2023CN¥7.3tCN¥2.2tCN¥233.1b37.8x31.2x3.3x
Sat, 07 Jan 2023CN¥7.0tCN¥2.2tCN¥232.2b36.1x30.2x3.2x
Mon, 05 Dec 2022CN¥7.0tCN¥2.2tCN¥231.9b37.5x30.3x3.2x
Price to Earnings Ratio

30.3x


Total Market Cap: CN¥7.0tTotal Earnings: CN¥231.9bTotal Revenue: CN¥2.2tTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Sector Price to Earnings3Y Average 35.7x202320242025
Current Industry PE
  • Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 44.1x which is higher than its 3-year average PE of 35.7x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 14% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare sector?

CN Market-1.89%
Healthcare-0.48%
Healthtech2.78%
Life Sciences0.93%
Pharma0.61%
Biotech-0.76%
Healthcare Services-2.27%
Medical Equipment-2.77%
Industry PE
  • Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 70.8x.
    • Analysts are expecting annual earnings growth of 42.7%, which is higher than its past year's earnings decline of 8.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 89% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Pharma industry is expected to see its earnings grow by 20% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
600276 Jiangsu Hengrui PharmaceuticalsLtdCN¥62.092.4%
+CN¥9.7b		24.9%PE55.1x
688506 Sichuan Biokin PharmaceuticalLtdCN¥384.992.6%
+CN¥4.1b		75.5%PS71.4x
300255 Hebei Changshan Biochemical PharmaceuticalCN¥61.307.0%
+CN¥3.7b		221.3%PS60.7x
002317 Guangdong Zhongsheng PharmaceuticalCN¥26.6114.3%
+CN¥2.8b		104.5%PS9.2x
002422 Sichuan Kelun PharmaceuticalCN¥34.464.9%
+CN¥2.5b		7.1%PE32.9x

Latest News

603259
CN¥92.20
WuXi AppTec
7D
-1.6%
1Y
86.6%

603259: New Regional Partnerships And Margin Gains Will Drive Future Performance

Analysts have slightly raised their price target for WuXi AppTec from $124.47 to $125.68. They cite refinements in their valuation models and modest improvements in projected profit margins as the reasons for this adjustment.
002422
CN¥34.46
Sichuan Kelun Pharmaceutical
7D
4.9%
1Y
7.1%

002422: Interim Dividend Approval Will Support Profitable Outlook Into 2025

Analysts have slightly lowered their price target for Sichuan Kelun Pharmaceutical from ¥40.92 to ¥40.59. This change is due to more cautious assumptions for revenue growth and discount rates, while maintaining a broadly favorable outlook on profitability and valuation metrics.
300015
CN¥11.40
Aier Eye Hospital Group
7D
-4.3%
1Y
-20.3%
300760
CN¥196.30
Shenzhen Mindray Bio-Medical Electronics
7D
-1.3%
1Y
-24.5%
688506
CN¥384.99
Sichuan Biokin PharmaceuticalLtd
7D
2.6%
1Y
75.5%
603122
CN¥22.16
Cowealth Medical ChinaLtd
7D
-15.4%
1Y
195.5%
688266
CN¥110.10
Suzhou Zelgen Biopharmaceuticals
7D
7.1%
1Y
60.5%
002317
CN¥26.61
Guangdong Zhongsheng Pharmaceutical
7D
14.3%
1Y
104.5%
300255
CN¥61.30
Hebei Changshan Biochemical Pharmaceutical
7D
7.0%
1Y
221.3%
603392
CN¥49.09
Beijing Wantai Biological Pharmacy Enterprise
7D
-8.0%
1Y
-31.8%
300832
CN¥58.28
Shenzhen New Industries Biomedical Engineering
7D
-8.1%
1Y
-8.3%
300204
CN¥30.10
Staidson (Beijing) BioPharmaceuticals
7D
-10.8%
1Y
245.2%
300765
CN¥33.03
CSPC Innovation Pharmaceutical
7D
3.5%
1Y
14.8%
600276
CN¥62.09
Jiangsu Hengrui PharmaceuticalsLtd
7D
2.4%
1Y
24.9%
300677
CN¥41.53
Intco Medical Technology
7D
6.8%
1Y
59.7%
688617
CN¥234.84
APT Medical
7D
-10.1%
1Y
-3.3%